Graft Options in Posterolateral and Posterior Interbody Lumbar Fusion
暂无分享,去创建一个
[1] S. Glassman,et al. Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft. , 2009, The spine journal : official journal of the North American Spine Society.
[2] T. Albert,et al. Complications associated with single-level transforaminal lumbar interbody fusion. , 2009, The spine journal : official journal of the North American Spine Society.
[3] S. Glassman,et al. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. , 2009, The Journal of bone and joint surgery. American volume.
[4] M. Rahm,et al. Clinical and radiographic assessment of transforaminal lumbar interbody fusion using HEALOS collagen-hydroxyapatite sponge with autologous bone marrow aspirate. , 2009, The spine journal : official journal of the North American Spine Society.
[5] N. Epstein. An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate. , 2008, The spine journal : official journal of the North American Spine Society.
[6] L. Dai,et al. Single-Level Instrumented Posterolateral Fusion of Lumbar Spine With &bgr;-Tricalcium Phosphate Versus Autograft: A Prospective, Randomized Study With 3-Year Follow-up , 2008, Spine.
[7] T. Albert,et al. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. , 2008, The spine journal : official journal of the North American Spine Society.
[8] S. Glassman,et al. Adverse Events in Patients Re-Exposed to Bone Morphogenetic Protein for Spine Surgery , 2008, Spine.
[9] M. Pećina,et al. Re: Burkus J K, Sandhu H S, Gornet M F. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft. Spine 2006;31:775-81. , 2008, Spine.
[10] M. Pećina,et al. Re: Burkus J K, Transfeldt E E, Kitchel S H, et al. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-408. , 2008, Spine.
[11] T. Damron,et al. Use of 3D β-tricalcium phosphate (Vitoss®) scaffolds in repairing bone defects , 2007 .
[12] K. Lewandrowski,et al. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. , 2007, The spine journal : official journal of the North American Spine Society.
[13] W. Dhert,et al. The Incidence of Donor Site Pain After Bone Graft Harvesting From the Posterior Iliac Crest May Be Overestimated: A Study on Spine Fracture Patients , 2007, Spine.
[14] S. Boden,et al. The Efficacy of rhBMP-2 for Posterolateral Lumbar Fusion in Smokers , 2007, Spine.
[15] N. Haas,et al. Quantification of various growth factors in different demineralized bone matrix preparations. , 2007, Journal of biomedical materials research. Part A.
[16] Jay R. Lieberman,et al. A comparison of commercially available demineralized bone matrix for spinal fusion , 2007, European Spine Journal.
[17] James N Weinstein,et al. United States’ Trends and Regional Variations in Lumbar Spine Surgery: 1992–2003 , 2006, Spine.
[18] S. Glassman,et al. Clinical Outcomes and Fusion Success at 2 Years of Single-Level Instrumented Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix Versus Iliac Crest Bone Graft , 2006, Spine.
[19] Matthew Shaw,et al. Healos and Bone Marrow Aspirate Used for Lumbar Spine Fusion: A Case Controlled Study Comparing Healos With Autograft , 2006, Spine.
[20] N. Epstein. A Preliminary Study of the Efficacy of Beta Tricalcium Phosphate as a Bone Expander for Instrumented Posterolateral Lumbar Fusions , 2006, Journal of spinal disorders & techniques.
[21] S. Kitchel. A preliminary comparative study of radiographic results using mineralized collagen and bone marrow aspirate versus autologous bone in the same patients undergoing posterior lumbar interbody fusion with instrumented posterolateral lumbar fusion. , 2006, The spine journal : official journal of the North American Spine Society.
[22] R. Delamarter,et al. Intervariability and Intravariability of Bone Morphogenetic Proteins in Commercially Available Demineralized Bone Matrix Products , 2006, Spine.
[23] D. Sengupta,et al. Outcome of Local Bone Versus Autogenous Iliac Crest Bone Graft in the Instrumented Posterolateral Fusion of the Lumbar Spine , 2006, Spine.
[24] J. Burkus,et al. Influence of rhBMP-2 on the Healing Patterns Associated With Allograft Interbody Constructs in Comparison With Autograft , 2006, Spine.
[25] T. Albert,et al. Comparison of OP-1 Putty (rhBMP-7) to Iliac Crest Autograft for Posterolateral Lumbar Arthrodesis: A Minimum 2-Year Follow-up Pilot Study , 2005, Spine.
[26] K. Bulsara,et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. , 2005, Journal of neurosurgery. Spine.
[27] John R. Johnson,et al. Initial Fusion Rates With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix and a Hydroxyapatite and Tricalcium Phosphate/Collagen Carrier in Posterolateral Spinal Fusion , 2005, Spine.
[28] B. Barnes,et al. Lower Dose of rhBMP-2 Achieves Spine Fusion When Combined With an Osteoconductive Bulking Agent in Non-human Primates , 2005, Spine.
[29] S. Glassman,et al. Platelet Gel (AGF) Fails to Increase Fusion Rates in Instrumented Posterolateral Fusions , 2005, Spine.
[30] W. Hutton,et al. Comparison of Healos/Bone Marrow to INFUSE(rhBMP-2/ACS) With a Collagen-Ceramic Sponge Bulking Agent as Graft Substitutes for Lumbar Spine Fusion , 2005, Spine.
[31] K. Shinomiya,et al. Beta-tricalcium phosphate (beta-TCP) graft combined with bone marrow stromal cells (MSCs) for posterolateral spine fusion. , 2005, Journal of medical and dental sciences.
[32] Kevin T Foley,et al. Minimally Invasive Transforaminal Lumbar Interbody Fusion (TLIF): Technical Feasibility and Initial Results , 2005, Journal of spinal disorders & techniques.
[33] T. Albert,et al. A 2-year follow-up pilot study evaluating the safety and efficacy of op-1 putty (rhbmp-7) as an adjunct to iliac crest autograft in posterolateral lumbar fusions , 2005, European Spine Journal.
[34] F. Castro. Role of Activated Growth Factors in Lumbar Spinal Fusions , 2004, Journal of spinal disorders & techniques.
[35] Jay R Lieberman,et al. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. , 2004, The Journal of bone and joint surgery. American volume.
[36] T. Albert,et al. A Pilot Study Evaluating the Safety and Efficacy of OP-1 Putty (rhBMP-7) as a Replacement for Iliac Crest Autograft in Posterolateral Lumbar Arthrodesis for Degenerative Spondylolisthesis , 2004, Spine.
[37] C. Branch,et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.
[38] W. Walsh,et al. Spinal fusion using an autologous growth factor gel and a porous resorbable ceramic , 2004, European Spine Journal.
[39] B. Weiner,et al. Efficacy of Autologous Growth Factors in Lumbar Intertransverse Fusions , 2003, Spine.
[40] T. Kai,et al. In Vivo Evaluation of Bone Marrow Stromal-Derived Osteoblasts-Porous Calcium Phosphate Ceramic Composites as Bone Graft Substitute for Lumbar Intervertebral Spinal Fusion , 2003, Spine.
[41] T. Albert,et al. Donor Site Morbidity After Anterior Iliac Crest Bone Harvest for Single-Level Anterior Cervical Discectomy and Fusion , 2003, Spine.
[42] S. Boden,et al. Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.
[43] R. Balderston,et al. Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 , 2002, Spine.
[44] C. Dickman,et al. Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.
[45] R. Holmes,et al. Hydroxyapatite/Calcium Carbonate (HA/CC) vs. Plaster of Paris: A Histomorphometric and Radiographic Study in a Rabbit Tibial Defect Model , 2002, Calcified Tissue International.
[46] P. Holtom,et al. Comparison of Anterior and Posterior Iliac Crest Bone Grafts in Terms of Harvest-Site Morbidity and Functional Outcomes , 2002, The Journal of bone and joint surgery. American volume.
[47] W. Hutton,et al. Delivery of Recombinant Human Bone Morphogenetic Protein-2 Using a Compression-Resistant Matrix in Posterolateral Spine Fusion in the Rabbit and in the Non-Human Primate , 2002, Spine.
[48] P. Aspenberg,et al. Platelet concentrate increases bone ingrowth into porous hydroxyapatite. , 2002, Orthopedics.
[49] S. Boden. Evaluation of carriers of bone morphogenetic protein for spinal fusion. , 2001, Spine.
[50] M. Salamon,et al. The Role of Human Bone Morphogenetic Proteins in Spinal Fusion , 2000, The Journal of the American Academy of Orthopaedic Surgeons.
[51] S. Boden,et al. Posterolateral Lumbar Intertransverse Process Spine Arthrodesis With Recombinant Human Bone Morphogenetic Protein 2/Hydroxyapatite‐Tricalcium Phosphate After Laminectomy in the Nonhuman Primate , 1999, Spine.
[52] M. Marone,et al. Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: important lessons learned regarding dose, carrier, and safety. , 1999, Journal of spinal disorders.
[53] Paramore Cg. The safety of OP-1 for lumbar fusion with decompression-- a canine study. , 1999 .
[54] J. Wozney,et al. Safety of Recombinant Human Bone Morphogenetic Protein‐2 After Spinal Laminectomy in the Dog , 1999, Spine.
[55] L. Titus,et al. New formulations of demineralized bone matrix as a more effective graft alternative in experimental posterolateral lumbar spine arthrodesis. , 1999, Spine.
[56] W. Hutton,et al. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion. , 1999, Spine.
[57] J. Lotz,et al. Use of a Collagen‐Hydroxyapatite Matrix in Spinal Fusion: A Rabbit Model , 1998, Spine.
[58] V. Traynelis,et al. A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions. , 1998, Journal of neurosurgery.
[59] M. Mackay,et al. 1997 Volvo Award Winner in Clinical Studies: Degenerative Lumbar Spondylolisthesis With Spinal Stenosis: A Prospective, Randomized Study Comparing Decompressive Laminectomy and Arthrodesis With and Without Spinal Instrumentation , 1997, Spine.
[60] S. Eiskjær,et al. 1997 Volvo Award Winner in Clinical Studies: The Effect of Pedicle Screw Instrumentation on Functional Outcome and Fusion Rates in Posterolateral Lumbar Spinal Fusion: A Prospective, Randomized Clinical Study , 1997, Spine.
[61] J. Goulet,et al. Autogenous Iliac Crest Bone Graft: Complications and Functional Assessment , 1997, Clinical orthopaedics and related research.
[62] R. Delamarter,et al. Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.
[63] Takashi Nakamura,et al. Establishment of bone morphogenetic protein 2 responsive chondrogenic cell line , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[64] W. Hutton,et al. Experimental Spinal Fusion With Recombinant Human Bone Morphogenetic Protein‐2 , 1995, Spine.
[65] Marc A. Asher,et al. Iliac Crest Bone Graft Harvest Donor Site Morbidity: A Statistical Evaluation , 1995, Spine.
[66] Banwart Jc,et al. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. , 1995 .
[67] T. Zdeblick. A prospective, randomized study of lumbar fusion. Preliminary results. , 1993, Spine.
[68] A. Levine,et al. Chronic Donor Site Pain Complicating Bone Graft Harvesting From the Posterior Iliac Crest for Spinal Fusion , 1992, Spine.
[69] H N Herkowitz,et al. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. , 1991, The Journal of bone and joint surgery. American volume.
[70] V. Rosen,et al. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[71] V. Rosen,et al. Growth factors influencing bone development , 1990, Journal of Cell Science.
[72] B. Summers,et al. Donor site pain from the ilium. A complication of lumbar spine fusion. , 1989, The Journal of bone and joint surgery. British volume.
[73] V. Rosen,et al. Novel regulators of bone formation: molecular clones and activities. , 1988, Science.
[74] M. Urist,et al. Bone: Formation by Autoinduction , 1965, Science.
[75] T. Damron. Use of 3D beta-tricalcium phosphate (Vitoss) scaffolds in repairing bone defects. , 2007, Nanomedicine.
[76] John R. Johnson,et al. Posterolateral lumbar spine fusion with INFUSE bone graft. , 2007, The spine journal : official journal of the North American Spine Society.
[77] J. Szatkowski,et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.
[78] B. Cunningham,et al. Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction. , 2002, The spine journal : official journal of the North American Spine Society.
[79] M. Hadley,et al. The safety of OP-1 for lumbar fusion with decompression-- a canine study. , 1999, Neurosurgery.
[80] V. Rosen,et al. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.
[81] V. Rosen,et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. , 1996, Growth factors.
[82] D. Kingsley,et al. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.
[83] M. Chapman,et al. Morbidity at bone graft donor sites. , 1989, Journal of orthopaedic trauma.
[84] 喜田みどり. 悪性グリオーマに対する放射線治療 : 照射野因子に関する prospective randomized clinical study , 1989 .